The Ohio State University Comprehensive Cancer Center

This is your central portal for breaking news, the latest research and important updates from The Ohio State University Comprehensive Cancer Center. Bookmark this page and check back often for updates.

Advanced Practice

APPs ‘integral,’ distinct part of the oncology workforce

HemOnc Today, December 25, 2019
Robin M. Rosselet, DNP, APRN-CNP/CNS, AOCN®
As advanced practice registered nurses, or APRNs — not doctors and not registered nurses — we often find ourselves straddling a chasm…
Advanced Practice

Treating the patient throughout the surgical process using evidence-based practice

HemOnc Today, November 25, 2019
Lisa Parks, MS, APRN-CNP, ANP-BC
Surgical care often is based on learned protocols that are not necessarily based on science. Enhanced recovery after surgery (ERAS), however, uses…
Feature

‘Surprising’ link between ibrutinib, hypertension spurs further study

November 19, 2019
Ibrutinib, a paradigm-changing drug for the treatment of various blood cancers, appeared to be more closely associated with new or worsened…
Meeting NewsPerspective

African Americans, Hispanics less likely than whites to use hospice for pancreatic cancer

October 23, 2019
African American and Hispanic patients who underwent pancreatectomy for pancreatic cancer appeared less likely than their white counterparts to…

Ohio State cancer center appoints hematology division director

September 12, 2019
Yiping Yang, MD, PhD, has been appointed director of the division of hematology at The Ohio State University Comprehensive Cancer Center —…

Ohio State’s cancer hospital names CEO

September 7, 2019
William Farrar, MD, has been named CEO of The Ohio State University Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. …
In the Journals

Autologous HSCT consolidation shows no benefit for certain patients with B-cell lymphomas

September 4, 2019
Upfront autologous hematopoietic stem cell transplantation consolidation did not appear to benefit patients with aggressive B-cell non-Hodgkin…

American Society for Radiation Oncology members receive fellow designation

August 8, 2019
American Society for Radiation Oncology designated 26 members to receive ASTRO fellow designation. The honorees will be recognized during the…
Meeting News

Conquer Cancer Foundation presents Merit Awards at ASCO

June 6, 2019
CHICAGO — The Conquer Cancer Foundation of ASCO presented ASCO Annual Meeting Merit Awards to more than 100 oncology professionals. The awards…
Meeting News

ASCO task force plans ‘new approaches’ to close rural cancer care gap

April 11, 2019
Patients with cancer who reside in rural areas routinely deal with logistical issues that affect their ability to receive treatment, often leading to…
Point/Counter

Is ibrutinib-based therapy the preferred initial treatment for all patients with CLL?

HemOnc Today, April 10, 2019
POINT CLL is the most common leukemia among adults. Standard treatment is combination chemoimmunotherapy with regimens such as chlorambucil plus…
Cover Story

Advances in chronic lymphocytic leukemia suggest progress is ‘visible on the horizon’

HemOnc Today, April 10, 2019
The transition from primarily chemotherapy-based approaches to targeted therapies revolutionized treatment of chronic lymphocytic leukemia, the most…
In the Journals

Mismatch repair deficiency linked to increased risk for endometrial cancer recurrence

February 25, 2019
Women with high-intermediate-risk endometrioid endometrial cancer and defective DNA mismatch repair had higher recurrence rates and poorer RFS than…
Feature

Stress linked to poor outcomes in chronic lymphocytic leukemia

December 31, 2018
Stress appeared associated with immune and inflammatory processes that contribute to cancer cell proliferation and survival among patients with…
Meeting NewsPerspective

Ibrutinib alone, with rituximab improves PFS in chronic lymphocytic leukemia

December 1, 2018
SAN DIEGO — The use of ibrutinib alone or with rituximab prolonged PFS compared with bendamustine plus rituximab among previously untreated…

The Ohio State Comprehensive Cancer Center appoints surgical oncology director

October 6, 2018
Allan Tsung, MD, has been appointed director of the division of surgical oncology at The Ohio State University Comprehensive Cancer Center —…
Cover Story

Efficacy data, cost-effectiveness will guide decision to expand HPV vaccination to older adults

HemOnc Today, September 10, 2018
The number of Americans eligible to receive the HPV vaccine could expand dramatically this fall. The HPV 9-valent vaccine, recombinant (Gardasil 9…

American Society for Radiation Oncology members receive fellow designation

July 28, 2018
American Society for Radiation Oncology designated 35 members as ASTRO fellows. The honorees will be recognized during the society’s annual…

City of Hope appoints chief operating officer

July 26, 2018
Jeff A. Walker has been appointed chief operating officer at City of Hope. Walker — whose appointment will take effect Aug. 1 — will…
Cover Story

Rapid autopsy holds ‘great power’ for deciphering tumor heterogeneity in various cancers

HemOnc Today, July 25, 2018
Rapid autopsy programs have the potential to greatly inform cancer research by unearthing how a tumor unfolds over time at different disease sites. A…